Comprehensive analysis of HIV Gag-specific IFN-γ response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia

European Journal of Immunology

Volumn 38, Issue 12, 2008, Pages 3549-3560

  Ondondo, Beatrice O ^a,b,c   Rowland Jones, Sarah L ^a,b   Dorrell, Lucy ^a   Peterson, Kevin ^b   Cotten, Matthew ^b   Whittle, Hilton ^b   Jaye, Assan ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cellular immunology; HIV; Interferon gamma; T cells

Indexed keywords

GAG PROTEIN; GAG PROTEIN[1-80]; GAG PROTEIN[141-220]; GAG PROTEIN[221-290]; GAG PROTEIN[281-360]; GAG PROTEIN[71-150]; GAMMA INTERFERON; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; PEPTIDE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; DRUG POTENCY; ENZYME LINKED IMMUNOSPOT ASSAY; GAMBIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOGENICITY; LYMPHOCYTE ACTIVATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN TARGETING; VIRUS LOAD; VIRUS REPLICATION; AMINO ACID SEQUENCE; CELL CULTURE; CHEMISTRY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; MOLECULAR GENETICS;

ADULT; AGED; AMINO ACID SEQUENCE; CELLS, CULTURED; COHORT STUDIES; CROSS REACTIONS; FEMALE; GAMBIA; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 59749085651     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838759     Document Type: Article

References (43)

1. Berry, N., Ariyoshi, K., Jaffar, S., Sabally, S., Corrah, T., Tedder, R. and Whittle, H., Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1998. 1: 457-468.
2. Berry, N., Ariyoshi, K., Jobe, O., Ngum, P. T., Corrah, T., Wilkins, A., Whittle, H. et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res. Hum. Retroviruses 1994. 10: 1031-1037.
3. + cells is faster in HIV-1 than in HIV-2 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997. 16: 327-332.
4. Barin, F., M'Boup, S., Denis, F., Kanki, P., Allan, J. S., Lee ,T. H. and Essex, M., Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 1985. 2: 1387-1389.
5. Schramm, B., Penn, M. L., Palacios, E. H., Grant, R. M., Kirchhoff, F. and Goldsmith, M. A., Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J. Virol. 2000. 74: 9594-9600.
6. Hanson, A., Sarr, A. D., Shea, A., Jones, N., Mboup, S., Kanki, P. and Cao, H., Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: Differential mechanism for immunoprotection. AIDS Res. Hum. Retroviruses 2005. 21: 791-798.
7. Alatrakchi, N., Damond, F., Matheron, S., Beretta-Tempelhoff, S., Campa, P., Carcelain, G., Brun-Vezinet, F. and Autran, B., Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection. AIDS 2006. 20: 29-34.
8. + T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 2006. 176: 6973-6981.
9. Nuvor, S. V., van der Sande, M., Rowland-Jones, S.,Whittle, H. and Jaye, A., Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall. J. Virol. 2006. 80: 2529-2538.
10. Jaye, A., Sarge-Njie, R., Schim van der Loeff, M., Todd, J., Alabi, A., Sabally, S., Corrah, T. et al. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. J. Infect. Dis. 2004. 189: 498-505.
11. Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A., DialloAgne, H., Critchlow, C.W. et al. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J. Virol. 2004. 78: 13934-13942.
12. Duvall, M. G., Precopio, M. L., Ambrozak, D. A., Jaye, A., McMichael, A. J., Whittle, H. C., Roederer, M. et al. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 2008. 38: 350-363.
13. + TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J. Immunol. 2003. 171: 307-316.
14. Leligdowicz, A., Yindom, L. M., Onyango, C., Sarge-Njie, R., Alabi, A., Cotten, M., Vincent, T. et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J. Clin. Invest. 2007. 117: 3067-3074.
15. Kurle, S., Tripathy, S., Jadhav, S., Agnihotri, K. and Paranjape, R., Fulllength gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res. Hum. Retroviruses 2004. 20: 1113-1118.
16. Klein,M. R., van Baalen, C. A., Holwerda, A.M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K., Osterhaus, A. D. et al., Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 1995. 181: 1365-1372.
17. Phillips, R. E., Rowland-Jones, S. L., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991. 354: 453-459.
18. Riviere, Y., McChesney, M. B., Porrot, F., Tanneau-Salvadori, F., Sansonetti, P., Lopez, O., Pialoux, G. et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses 1995. 11: 903-907.
19. Ramduth, D., Chetty, P., Mngquandaniso, N. C., Nene, N., Harlow, J. D., Honeyborne, I., Ntumba, N. et al. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J. Infect. Dis. 2005. 192: 1588-1596.
20. Kiepiela, P., Ngumbela, K., Thobakgale, C., Ramduth, D., Honeyborne, I., Moodley, E., Reddy, S. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007. 13: 46-53.
21. Masemola, A., Mashishi, T., Khoury, G., Mohube, P., Mokgotho, P., Vardas, E., Colvin, M. et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 2004. 78: 3233-3243.
22. Edwards, B. H., Bansal, A., Sabbaj, S., Bakari, J., Mulligan, M. J. and Goepfert, P. A., Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 2002. 76: 2298-2305.
23. Bertoletti, A., Cham, F., McAdam, S., Rostron, T., Rowland-Jones, S., Sabally, S., Corrah, T. et al. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J. Virol. 1998. 72: 2439-2448.
24. Gotch, F., McAdam, S. N., Allsopp, C. E., Gallimore, A., Elvin, J., Kieny, M. P., Hill, A. V. et al. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 1993. 151: 3361-3369.
25. Rowland-Jones, S. L., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F. M., McAdam, S.,Whitby, D. et al. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1995. 1: 59-64.
26. Rowland-Jones, S., Colbert, R. A., Dong, T., McAdam, S., Brown, M., Ariyoshi, K., Sabally, S. et al. Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705. AIDS 1998. 12: 1391-1393.
27. Ondondo, B. O., Yang, H., Dong, T., di Gleria, K., Suttill, A., Conlon, C., Brown, D. et al. Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses. Eur. J. Immunol. 2006. 36: 2585-2594.
28. Claverie, J. M., Kourilsky, P., Langlade-Demoyen, P., ChalufourProchnicka, A., Dadaglio, G., Tekaia, F., Plata, F. et al. T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein. Eur. J. Immunol. 1988. 18: 1547-1553.
29. Kaufmann, D. E., Bailey, P. M., Sidney, J., Wagner, B., Norris, P. J., Johnston, M. N., Cosimi, L. A. et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 2004. 78: 4463-4477.
30. Malhotra, U., Holte, S., Dutta, S., Berrey, M. M., Delpit, E., Koelle, D. M., Sette, A. et al. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J. Clin. Invest. 2001. 107: 505-517.
31. Kostense, S., Ogg, G. S., Manting, E. H., Gillespie, G., Joling, J., Vandenberghe, K., Veenhof, E. Z. et al. High viral burden in the presence of major HIV-specific CD8(1) T cell expansions: Evidence for impaired CTL effector function. Eur. J. Immunol. 2001. 31: 677-686.
32. Gillespie, G. M., Pinheiro, S., Sayeid-Al-Jamee, M., Alabi, A., Kaye, S., Sabally, S., Sarge-Njie, R. et al. CD81 T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur. J. Immunol. 2005. 35: 1445-1453.
33. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106.
34. Dorrell, L., Dong, T., Ogg, G. S., Lister, S., McAdam, S., Rostron, T., Conlon, C. et al. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa. J. Virol. 1999. 73: 1708-1714.
35. Brander, C., Hartman, K. E., Trocha, A. K., Jones, N. G., Johnson, R. P., Korber, B., Wentworth, P. et al. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 1998. 101: 2559-2566.
36. Masemola, A. M., Mashishi, T. N., Khoury, G., Bredell, H., Paximadis, M., Mathebula, T., Barkhan, D. et al. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J. Immunol. 2004. 173: 4607-4617.
37. Dorrell, L., Willcox, B. E., Jones, E. Y., Gillespie, G., Njai, H., Sabally, S., Jaye, A. et al. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53. Eur. J. Immunol. 2001. 31: 1747-1756.
38. Andersson, S., Norrgren, H., Dias, F., Biberfeld, G. and Albert, J., Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 1999. 262: 312-320.
39. Frahm, N., Korber, B.T., Adams, C. M., Szinger, J. J., Draenert, R., Addo, M.M., Feeney, M. E. et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 2004. 78: 2187-2200.
40. Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J. and Welsh, K. I., Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995. 46: 355-367.
41. Clavel, F., Guyader, M., Guetard, D., Salle, M., Montagnier, L. and Alizon, M., Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature 1986. 324: 691-695.
42. Dorrell, L., Yang, H., Ondondo, B., Dong, T., di Gleria, K., Suttill, A., Conlon, C. et al. Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine. J. Virol. 2006. 80: 4705-4716.
43. Mwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G.-T., Beattie, T. et al. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: Stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J. Gen. Virol. 2004. 85: 911-919.